Patents | Intellepedia

Indian Patent and Design Statistics 2024 (November 22nd to 29th)

This weekly report details Indian patent and design statistics from November 22nd to 29th, 2024, highlighting trends in publications, grants, and registrations. Compiled by BananaIP, the analysis offers an objective view of official IP data for legal and industry professionals.

Madras High Court Upholds Patent Validity in Embio Limited vs. Malladi Drugs & Pharmaceuticals

The Madras High Court affirmed the validity of Malladi Drugs’ patent for chiral beta-amino alcohols, highlighting the invention’s novelty and inventive step. The judgment clarifies key principles on patent revocation and the definition of a “person interested” under Indian patent law.

Patent Application Rejection Set Aside for Improper Citation of Withdrawn Prior Art

The Madras High Court overturned a patent rejection due to improper citation of withdrawn prior art, directing a fresh examination. The case highlights the necessity for strict compliance with procedural safeguards in Indian patent proceedings.

2024 IP Report Indicates Increase in Patent and Design Filings with India Among Key Contributors

The 2024 WIPO IP report shows that patent and design filings have risen globally, with India emerging as a major contributor. Indian resident patent filings surpassed non-residents for the first time, highlighting increased local innovation and engagement.

Court restores patent application despite missed deadline to file request for examination

The Delhi High Court restored a patent application that was deemed withdrawn after a missed Form 18 deadline caused by agent negligence. The Court held that applicants should not be penalised for their representative’s errors, affirming the applicant’s diligent intent.

Delhi High Court Orders Restoration of Patent Lapsed Due to Communication Error of the Patent Office

The Delhi High Court ordered restoration of a lapsed patent after finding that the Patent Office’s communication error led to non-payment of renewal fees. The judgment highlights the responsibility of authorities to ensure proper notification in patent matters.

Methods for Antibody Production in Genetically Modified Animals are Patentable; they are not covered under Section 3(i) Exclusion

The Madras High Court ruled that methods for producing antibodies in genetically modified animals are patentable under Indian law and are not excluded by Section 3(i). This decision clarifies the scope of patent eligibility for biotechnological inventions involving animal models.

Claim Amendments within the Scope of Patent Specification are Permissible, the Delhi High Court reiterates

The Delhi High Court has reaffirmed that claim amendments falling within the scope of the original patent specification are permissible under Indian law. The judgment provides clarity on Section 59(1) of the Patents Act and sets important precedent for future patent amendment cases.

Blackberry blacks out in case relating to patentability of algorithmic processes

The Delhi High Court dismissed Blackberry’s appeal against refusal of its patent application, holding that algorithmic processes remain excluded from patent protection under Indian law. The decision clarifies the interpretation of Section 3k with respect to software and computer-related inventions.

Section 3(j), Essentially biological processes and human intervention

The Madras High Court considered whether human intervention in a plant breeding method excluded it from section 3(j) of the Patents Act. The case was remanded to the Patent Office, underlining the importance of clear reasoning in patent refusals involving essentially biological processes.